Overview
Lung cancer remains the leading cause of cancer mortality worldwide. Patients from the EMRO region remain underrepresented in genomic databases, clinical trials, and translational research. This joint session will strengthen regional collaboration on precision oncology, molecular pathology, and lung cancer research.
Related Files